Figure 7. ¹⁸F-FDG/microPET imaging was used for monitoring therapeutic response in vivo.

(A) On the 56^th day post treatment, microPET was performed at 30 min after intravenous injection of 19.6–20.1 MBq ¹⁸F-FDG, and images were acquired for 30 min. The experiments were repeated three times and one out of three is shown here. (B) The SUV of the tumors were quantified in different treatment groups (n=3/group). *P<0.05, **P<0.01 and ***P<0.001, all treatments vs. control. ^$$P<0.01, orlistat and combination vs. castration. ^##P<0.01, combination vs. orlistat. Experiments were repeated twice.